Home
overview

The conference listed on this page was held in 2005. For information on the 2010 conference go to www.smi-online.co.uk/2010europricing.asp  

European Pharmaceutical Pricing & Reimbursement Conference 2010

  


It is essential for pharmaceutical companies to understand fully the market environment and the principles governing pricing in these markets.  The pricing of new products is crucial.  If the price is set too high, the product may fail to gain reimbursement, if the price is too low, profitability will be reduced.

SMi's 11th Annual European Pharmaceutical Pricing and Reimbursement Conference in Italy is a must attend event.  This year the agenda will include detailed updates of the key regulatory developments and an in-depth analysis of the issues surrounding pricing and reimbursement including the latest trends and the future of parallel trade.  The conference will include country-specific case studies from the following markets - UK, Belgium, Italy, Germany and Central Europe.

Gain an insight from the key industry leaders in the field including:

Katarina Bartikova, Head, Drug & Medical Devices Department, Ministry of Health, Czech Republic
Ulrich Dietz, Head, Reimbursement Regulation Unit, German Ministry of Health
Luis González Vaqué, Adviser, European Commission
Julian Mount, Senior Director & Head, European Trade, Pfizer
Dr Kevin Loth, Director, European Public Affairs, Novartis
Dr Anne-Toni Rodgers, Director, Government Affairs & Public Policy, Europe, Baxter
Dr Nick Schulze-Solce, Director, Corporate Affairs, Lilly Pharma
Toon Digneffe, Manager, Government Affairs & Public Policy, Baxter
Dr Ann-Katrin Gonschior, International Product Manager, Altana Pharma

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Anne-Toni Rodgers

Anne-Toni Rodgers, Director, Government Affairs & Public Policy Europe, Baxter World Trade S. A

9:10 KEYNOTE ADDRESS

Luis  González Vaqué

Luis González Vaqué, Advisor, European Commission

  • National price and reimbursement schemes: the ECJ case law
  • Parallel trade: Intellectual Propertry and Completition Law
  • The impact of the accession of ten new member states
  • Candidate countries (Bulgaria and Romania)
  • 9:50 NATIONAL PRICE AND REIMBURSEMENT NEGOTIATIONS

    Kevin Loth

    Kevin Loth, Director, European Public Affairs, Novartis

  • Introduction to the scope and influence of the Transparency Directive
  • Overview of the role the Transparency Directive can play in local price and reimbursement negotiations
  • Results of the Market Access Delay study - do Member States comply with the Directive?
  • Examples of how the Transparency Directive has provided the stimulus for change
  • 10:30 Morning Coffee

    11:00 THE LINK BETWEEN REIMBURSEMENT POLICY AND INNOVATION

    Jon Sussex

    Jon Sussex, Associate Director, Office Of Health Econimics

  • Cost containment policies may refer to "innovation" but misrepresent it
  • The consumer/patient is the real judge of how a medicine is innovative
  • Innovation in all sectors, not just medicines, is also often incremental and cumulative rather than breakthrough
  • Pricing and reimbursement plicies that forget that will block wocially valuable R&D
  • 11:40 LAUNCH SEQUENCING FOR PHARMACEUTICAL PRODUCTS

    Ann-Katrin Gonschior

    Ann-Katrin Gonschior, International Product Manager, ALTANA Pharma

  • Identifying a framework for sequencing
  • What are the implications
  • How to preserve your European price level
  • 12:20 Networking Lunch

    13:50 THE NEW PRICING AND REIMBURSEMENT PROCESS

  • Recent changes in pricing policy
  • Increased regional control
  • Problems raised
  • Pharmacoeconomics in Italy
  • Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

    Lorenzo Terranova

    Lorenzo Terranova, Head, Economic Affairs, Farmindustria

    15:10 Afternoon Tea

    15:40 PHARMACEUTICALS PRICE REGULATION SCHEME IN BELGIUM

    Toon  Digneffe

    Toon Digneffe, Manager, Government Affairs & Public Policy, Baxter World Trade S. A

  • How to interpret and apply the regulations
  • How do you get a return?
  • Securing the provision of safe and effective medicines at reasonable prices
  • Promoting a strong and profitable pharmaceutical industry leading to new and improved medicines
  • Encouraging the efficient and competitive development and supply of medicines to pharmaceutical markets
  • 16:20 DRGS (DIAGNOSTIC RELATED GROUPS) & HRGS (HEALTHCARE RELATED GROUPS)

    Ulrich Dietz

    Ulrich Dietz, Head, Unit Reimbursement of Pharmaceuticals, Ministry of Health, Germany

  • The impact on pricing of existing products
  • The impact on reimbursement of new products entering the market
  • Will the drastically cut healthcare costs damage the medical device industry?
  • Will this work in Germany, how?
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Janice Haigh

    Janice Haigh, Principal, Cambridge Pharma Consultancy

    9:10 GERMAN HEALTHCARE SYSTEM

    Nick Schulze-Solce

    Nick Schulze-Solce, Director, Corporate Affairs, Lilly Pharma Holding

  • Reference Price System
  • IQWIG
  • Other developments
  • 9:50 PRICING AND REIMBURSEMENT IN CENTRAL EUROPEAN MARKETS

    Anne-Toni Rodgers

    Anne-Toni Rodgers, Director, Government Affairs & Public Policy Europe, Baxter World Trade S. A

  • Prioritising the markets
  • What's the current situation in the major markets
  • Trends for the future
  • What should you be doing?
  • 10:30 Morning Coffee

    11:00 MATCH - MULTIDISCIPLINARY ASSESSMENT OF TECHNOLOGY CENTRE FOR HEALTHCARE

    Alan Brown

    Alan Brown, Research Fellow, MATCH, University Of Ulster

  • Smoothing the route to development
  • Balancing the perspectives
  • Bringing a product to market that provides a profit
  • Meeting regulatory requirements
  • Responding to the ever-increasing demands of users
  • 11:40 QUANTIFYING THE IMPACT OF NICE APPRAISALS AND PARALLEL TRADE

  • Understanding the impact of NICE appraisals
  • How to quantify these effects in terms of price and volumes
  • When parallel trade becomes an issue
  • How to quantify this and develop strategies to maximise revenues
  • Joe Lawson

    Joe Lawson, Head, Business Development, Inpharmation

    Gary Johnson

    Gary Johnson, Director, Inpharmation

    12:20 Networking Lunch

    14:00 INTERACTIVE PANEL DISCUSSION

    Suggested topics include:

  • The new EU accession markets - minimising the threat of parallel trade in an enlarged EU
  • Identifying potential growth segments in the new EU markets
  • The emerging role of Health Technology Assessment in the EU - a threat or an opportunity?:
  • Ann-Katrin Gonschior

    Ann-Katrin Gonschior, International Product Manager, ALTANA Pharma

    Kevin Loth

    Kevin Loth, Director, European Public Affairs, Novartis

    Nick Schulze-Solce

    Nick Schulze-Solce, Director, Corporate Affairs, Lilly Pharma Holding

    Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

    14:40 THE FUTURE OF PARALLEL TRADE IN EUROPE

    Janice Haigh

    Janice Haigh, Principal, Cambridge Pharma Consultancy

  • Update on the latest trends
  • Likely future developments and their impact
  • -  EU expansion

    -   Global parallel trade

  • What strategies can be employed to manage parallel trade
  • 15:20 PATIENT SAFETY AND THE SUPPLY CHAIN

    Julian Mount

    Julian Mount, Senior Director and Head of European Trade, Pfizer

  • Parallel traded medicines in EU
  • Enhancing patient safety
  • The Safety Chain
  • Pfizer's new distribution model
  • 16:00 Chairman’s Closing Remarks and Close of Day One

    +

    Workshops

    Meeting the Challenges of Reference Pricing
    Workshop

    Meeting the Challenges of Reference Pricing

    St Regis Grand Hotel
    8th November 2005
    Rome, Italy

    Pricing in the USA
    Workshop

    Pricing in the USA

    St Regis Grand Hotel
    11th November 2005
    Rome, Italy

    St Regis Grand Hotel

    Rome
    Italy

    St Regis Grand Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.